Evidence for the Role of Bevacizumab in the Treatment of Advanced Metastatic Breast Cancer: A Review

Breast Cancer: Targets and Therapy - New Zealand
doi 10.2147/bctt.s6511
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Related search

Evidence for a Role of Tumor-Derived Laminin-511 in the Metastatic Progression of Breast Cancer

American Journal of Pathology
Forensic MedicinePathology
2007English

Critical Appraisal of Bevacizumab in the Treatment of Metastatic Colorectal Cancer

OncoTargets and Therapy
OncologyPharmacology
2012English

Modeling Efficacy of Bevacizumab Treatment for Metastatic Colon Cancer

Journal of Cancer
Oncology
2013English

Systematic Review and Economic Evaluation of Bevacizumab and Cetuximab for the Treatment of Metastatic Colorectal Cancer

Health Technology Assessment
MedicineHealth Policy
2007English

Vectors for Treatment of Metastatic Breast Cancer

2005English

Eribulin Mesylate in the Treatment of Metastatic Breast Cancer

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2012English

Weekly Docetaxel in the Treatment of Metastatic Breast Cancer

Therapeutics and Clinical Risk Management
2008English

Influence of the American ODAC Statement on Austrian Bevacizumab Prescribing Practice for Metastatic Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
2012English

Treatment-Related Hypertension as a Pharmacodynamic Biomarker for the Efficacy of Bevacizumab in Advanced Pancreas Cancer

American Journal of Clinical Oncology: Cancer Clinical Trials
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy